Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 2006

View Archived Issues

Levetiracetam effective in human experimental pain

Increased heparanase expression correlated with invasive breast cancer

Progress update on ThromboView programs

Antisoma to evaluate EcoBiotics' rainforest anticancer compounds

CeNeS collaborates with Ergomed to finalize phase II trial plans for CNS-5161

New phase I/II trial evaluates BDM-E for diabetic macula edema

Phase III trials completed for KW-6002 in Parkinson's disease

Biotest and AERES Biomedical establish production system for BT-062

OP-145 for chronic otitis media completes phase I, begins phase II

CancerVax files to begin phase I trial with D93

Immtech completes SPA for DB-289 in Pneumocystis pneumonia

Ciclesonide nasal spray NDA accepted for review

Pivotal study begins for KeraPac in diabetic foot ulcers

GSK and Myogen form PAH partnership

Phase II pagoclone study in stuttering completes enrollment

Enrollment completed in first of two phase III studies for Sanctura XR

Neuren cleared to advance NNZ-2566 into phase I for traumatic brain injury

ATL-104 reduces duration of mucositis

Ceftobiprole demonstrates high cure rate in Gram-positive infections

Therapeutic agents for HIV infection claimed in recent patent literature

FDA Advisory Committee recommends return of Tysabri to market

Novel PKC-theta inhibitors emerge from Boehringer Ingelheim R&D

Recent patents report new possible treatments for respiratory diseases

RB-101: antidepressant without associated convulsions

The beneficial effects of argan oil phenolic extract for CHD

Safety of docetaxel in combination with immunotherapy shown in patients with prostate cancer

Efficacy of theophylline to treat allergic asthma improved by new delivery system

Potential application of Neovastat in inflammatory asthma reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...